Drawing for CANNAFEN

USPTO serial 79246444

CANNAFEN

Reviewed by CopyMark Law Group

Reg. 6077024Status 700Renewal
Filing date
Status date
Registration date
Jun 16, 2020
Examiner
BEN, LINDSEY HEATHER
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CANNAFEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for inhalers for the treatment of pain, neuropathy, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; pharmaceutical preparations and substances for use in chemotherapy; pharmaceutical preparations for inhalers for the treatment of pain, neuropathy, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; drug delivery agents in the nature of tablets, liquid medications, inhalers, nasal and oral sprays that facilitate the delivery of a wide range of pharmaceuticals; Transdermal patches and transdermal patches for medical treatment, both for the treatment of pain, neuropathy, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; all of the aforementioned goods containing cannabis that is solely synthetic in nature; sanitary preparations for medical purposes, vaccines, and sanitary sterilising preparations, all not containing cannabis or CBDACTIVE—
010Inhalers for medical purposes; medical inhalers; inhalers for medical use; inhalers for therapeutic use; therapeutic inhalers; inhalers for medical purposes, sold empty; all of the aforementioned goods either exclusively for use with cannabis that is solely synthetic in nature, or containing cannabis that is solely synthetic in natureACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 14, 2023WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Sep 14, 2023WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Jan 9, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 4, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 4, 2020FIMPFINAL DISPOSITION PROCESSED—
Sep 16, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 16, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 15, 2020OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 29, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 29, 2020OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 31, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 31, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 27, 2020GPNXNOTIFICATION PROCESSED BY IB—
Mar 11, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 11, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 11, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 27, 2020ALIEASSIGNED TO LIE—
Feb 21, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 21, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Feb 21, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 21, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 21, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 23, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 22, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 22, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 23, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 23, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 23, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 26, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 25, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 25, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 21, 2019RFNTREFUSAL PROCESSED BY IB—
May 24, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 20, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 5, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 4, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 4, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 17, 2019RFNTREFUSAL PROCESSED BY IB—
Dec 29, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 29, 2018RFRRREFUSAL PROCESSED BY MPU—
Dec 18, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 17, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2018DOCKASSIGNED TO EXAMINER—
Dec 11, 2018DOCKASSIGNED TO EXAMINER—
Dec 4, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 30, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 29, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance